Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Clinical trial NCT03988634 · COMPLETED

Trial details

NCT number: NCT03988634
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction (HFpEF)

Start date: 2019-06-29
Primary completion: 2022-12-14
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.